Effectiveness of steroid and local anesthetic injection for patients with functional ankle instability

ISRCTN ISRCTN51678104
DOI https://doi.org/10.1186/ISRCTN51678104
ClinicalTrials.gov (NCT) Nil known
Clinical Trials Information System (CTIS) Nil known
Protocol serial number Nil known
Sponsor National Natural Science Foundation of China
Funder National Natural Science Foundation of China
Submission date
08/01/2023
Registration date
11/01/2023
Last edited
07/02/2023
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Musculoskeletal Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
Steroid injection is a common treatment for musculoskeletal diseases. However, its effectiveness in functional ankle instability (FAI, a floppy loose ankle) is still controversial. The aim of this study is to find out whether a steroid and local anesthetic injection into the ankle improves ankle function more than health education.

Who can participate?
Patients aged 18 to 50 years with FAI

What does the study involve?
Participants are divided into two groups: the steroid group receives a steroid and local anesthetic injection, and the saline group receives a saline injection. For both groups, the follow-up is at 4, 8 and 12 weeks later.

What are the possible benefits and risks of participating?
Possible benefits include improvement in ankle function, and risks may include injection site infection and local soft tissue damage.

Where is the study run from?
Huashan Hospital, Fudan University (China)

When is the study starting and how long is it expected to run for?
January 2022 to January 2023

Who is funding the study?
National Natural Science Foundation of China

Who is the main contact?
Dr Yungu Chen, yungu_chen@163.com

Contact information

Dr Yungu Chen
Scientific

12 Middle Wulumuqi Road
Shanghai
200040
China

ORCiD logoORCID ID 0000-0002-8486-8098
Phone +86 (0)21 52889999
Email yungu_chen@163.com

Study information

Primary study designInterventional
Study designSingle-center interventional single-blinded randomized controlled trial
Secondary study designRandomised controlled trial
Study type Participant information sheet
Scientific titleClinical effectiveness of intra-articular steroid and local anesthetic injection for patients with functional ankle instability in the improvement of ankle function compared with health education
Study objectivesIntra-articular steroid and local anesthetic injection improves ankle function more than health education
Ethics approval(s)Approved 04/01/2022, Huashan Institutional Review Board (12 Middle Wulumuqi Road, Shanghai, China; +86 (0)21 5288045; licaihong199505@163.com), ref: KY2022-070
Health condition(s) or problem(s) studiedFunctional ankle instability
InterventionCurrent interventions as of 07/02/2023:

Randomization process: Patients are randomly assigned to two groups by an independent physician by choosing one of two sealed opaque envelopes. The allocation is performed by an independent researcher without knowing the treatment details.

Participants are divided into two groups: the steroid group receives an intra-articular steroid and local anesthetic injection (a mixture of 1 ml of 40 mg/ml triamcinolone and 2 ml 2% lidocaine) immediately after the baseline measurement, and the saline group receives a saline injection immediately after baseline measurement.

For both groups, the follow-up is at 4, 8 and 12 weeks after baseline measurement.

_____

Previous interventions:

Randomization process: Patients are randomly assigned to Group A, B or C by an independent physician by choosing one of three sealed opaque envelopes containing letters A to C, reflecting the three groups, respectively. The allocation is performed by an independent researcher without knowing the treatment details.

Participants are divided into three groups: group A receives health education, group B receives an intra-articular steroid and local anesthetic injection (a mixture of 1 ml of 40 mg/ml triamcinolone and 2 ml 2% lidocaine) immediately after the baseline measurement, and group C receives a saline injection immediately after baseline measurement.

For all three groups, the follow-up is at 4, 8 and 12 weeks after baseline measurement.
Intervention typeDrug
PhaseNot Applicable
Drug / device / biological / vaccine name(s)Triamcinolone, lidocaine
Primary outcome measure(s)

Pain is measured using a visual analogue scale (VAS) at baseline, 4, 8 and 12 weeks

Key secondary outcome measure(s)

1. Ankle function is measured by the Cumberland Ankle Instability Tool (CAIT) at baseline, 4, 8 and 12 weeks
2. Balance performance is measured by a center of pressure (COP) forceplate at baseline, 4, 8 and 12 weeks

Completion date31/01/2023

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexAll
Target sample size at registration60
Key inclusion criteria1. Aged 18 to 50 years
2. At least one episode of significant ankle sprain sustained no less than 12 months prior to the recruitment
3. At least one interrupted day of desired physical activity
4. Existing residual symptoms including recurrent ankle sprains, and/or at least two episodes of sprains and/or perceived ankle instability in the previous 6 months
5. Cumberland Ankle Instability Tool (CAIT) scores lower than 24
Key exclusion criteria1. A history of fracture requiring realignment or musculoskeletal surgery in either lower extremity
2. Osteoarthritis in either lower extremity, head trauma, inner ear disease, muscular dystrophy, or other conditions that could affect balance control
3. A history of acute injury to the lower extremity within 3 months before the enrollment
Date of first enrolment01/10/2022
Date of final enrolment30/10/2022

Locations

Countries of recruitment

  • China

Study participating centre

Huashan Hospital, Fudan University
12 Middle Wulumuqi Road
Jingan District
Shanghai
200040
China

Results and Publications

Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
IPD sharing planThe datasets generated during and/or analysed during the current study will be available on request from Prof. Xin Ma (prof.xin.ma@qq.com).
The type of data: all electronic Excel data used in the study
Date of availability: after publication in a journal
Whether consent from participants was required and obtained: All participants are required to provide written informed consent
Comments on data anonymization: All data are anonymized
Any ethical or legal restrictions: This study strictly complies with the local ethical and legal regulations

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Participant information sheet Participant information sheet 11/11/2025 11/11/2025 No Yes

Editorial Notes

07/02/2023: The following changes were made to the trial record:
1. The interventions were changed.
2. The plain English summary was updated to reflect these changes.
10/01/2023: Trial's existence confirmed by the Huashan Institutional Review Board.